SOPHROSYNE PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, February 27, 2020, a trademark application was filed for SOPHROSYNE PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the SOPHROSYNE PHARMACEUTICALS trademark a serial number of 88813781. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, September 14, 2023. This trademark is owned by Sophrosyne Holdings LLC. The SOPHROSYNE PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development for FDA-approved prescription medications to address alcohol use disorder (AUD) and other addiction disorders, excluding nutritional supplements
sophrosyne pharmaceuticals

General Information

Serial Number88813781
Word MarkSOPHROSYNE PHARMACEUTICALS
Filing DateThursday, February 27, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, September 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesResearch and development for FDA-approved prescription medications to address alcohol use disorder (AUD) and other addiction disorders, excluding nutritional supplements

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 9, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSophrosyne Holdings LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60661
Party NameSophrosyne Holdings LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60661

Trademark Events

Event DateEvent Description
Friday, September 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 14, 2023SOU EXTENSION 5 GRANTED
Wednesday, September 6, 2023SOU EXTENSION 5 FILED
Thursday, September 14, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 21, 2023SOU EXTENSION 4 GRANTED
Tuesday, February 21, 2023SOU EXTENSION 4 FILED
Tuesday, February 21, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 2, 2022SOU EXTENSION 3 GRANTED
Friday, September 2, 2022SOU EXTENSION 3 FILED
Friday, September 2, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 8, 2022SOU EXTENSION 2 GRANTED
Tuesday, February 8, 2022SOU EXTENSION 2 FILED
Tuesday, February 8, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 20, 2021SOU EXTENSION 1 GRANTED
Tuesday, July 20, 2021SOU EXTENSION 1 FILED
Tuesday, July 20, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 21, 2020NON-FINAL ACTION E-MAILED
Thursday, May 21, 2020NON-FINAL ACTION WRITTEN
Saturday, May 16, 2020ASSIGNED TO EXAMINER
Monday, March 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 5, 2020NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals sophrosyne addiction other disorders excluding supplements nutritional disorder alcohol approved development